Vection Technologies Targets $1.7m Revenue with Laerdal Healthcare Partnership

A Strategic Partnership in Healthcare Simulation

Vection Technologies Ltd (ASX:VR1) has announced a significant three-year partnership with Laerdal Italia S.r.l., a global leader in healthcare simulation. The deal, valued at $1.7 million, will see Vection’s extended reality (XR) and artificial intelligence (AI) portfolio integrated into Italy’s healthcare training sector, with the goal of transforming traditional clinical education into immersive, data-driven experiences.

Laerdal, known for its high-fidelity manikins and performance-tracking software, brings over six decades of expertise and a global footprint spanning 26 countries. This partnership leverages Laerdal’s established sales channels and trusted relationships with hospitals, universities, and emergency responders, providing Vection with immediate market access and brand visibility in a critical sector.

Innovating Clinical Training with XR and AI

The collaboration will combine Vection’s 3DFrame, EnWorks Remote Assistance, and Algho AI technologies with Laerdal’s conversational coaching tools. This integration promises to elevate healthcare simulations from static drills to interactive, photorealistic learning environments. Trainees will be able to explore detailed 3D anatomy, receive real-time remote guidance, and benefit from AI-driven conversational support that converts actions into measurable insights.

Such advancements are expected to enhance training outcomes and patient safety by providing clinicians and first responders with more effective, engaging educational tools. The partnership’s phased revenue targets, $350,000 in FY26, $600,000 in FY27, and $750,000 in FY28, reflect growing adoption and confidence in these technologies.

Expanding Horizons Beyond Italy

Italy serves as the initial launch market, but both companies have ambitious plans to extend this model across Laerdal’s broader European network and eventually on a global scale. Joint marketing initiatives, demonstration centers, and aligned product roadmaps will underpin this expansion, potentially setting a new standard for simulation-based healthcare education worldwide.

Vection’s Managing Director Gianmarco Biagi highlighted the strategic fit, noting Laerdal’s leadership in clinical education as an ideal platform for Vection’s XR and AI suite. Meanwhile, Laerdal Italia’s CEO Novella Callero emphasized the partnership’s potential to improve patient safety through enhanced, data-driven learning experiences.

While the agreement can be terminated with three months’ notice, the initial commitment signals strong mutual confidence in the commercial and educational benefits of this collaboration.